Our News on Newswise

Researchers Identify Potential Early Biomarker to Track Development of Dangerous Non-alcoholic Fatty Liver Disease

Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than one billion people worldwide. Even in children the numbers are overwhelming, with up to 80 percent of...
6-Apr-2020 5:10 PM EDT Add to Favorites

Joslin Research Ties Autoimmunity-Associated Heart Dilation to Potential Heart-Failure Risk in Type 1 Diabetes

There's a higher case fatality rate in type 1 than type 2 diabetes, which suggests different mechanisms for heart failure might be involved in type 1 diabetes.” Given the burden of heart failure in type 1 diabetes, the early identification of...
6-Apr-2020 12:05 PM EDT Add to Favorites

Brown Fat Can Burn Energy in an Unexpected Way

Joslin researchers have found a pathway that can boost the production of (heat-generating, fat-burning) brown fat cells without also creating unhelpful white fat cells. This finding suggests that the pathway the Joslin team uncovered might offer a...
6-Apr-2020 11:55 AM EDT Add to Favorites

Newswise: fundus-camera-use-for--examination-eye--in-hospital-514166630_2500x16601.jpeg

For the evaluation and treatment of diabetic eye disease, ultra-wide field imaging techniques cannot be used interchangeably

Diabetic retinopathy can be diagnosed and graded with the use of a newer scanning technology called ultra-wide field (UWF) imaging, a system that generates high-quality pictures showing most of the retina. Research from the Joslin Diabetes...
5-Mar-2020 3:35 PM EST Add to Favorites

New Closed-Loop System Offers Promise as Novel Treatment for Post-Bariatric Hypoglycemia

Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can't detect is really an unsafe situation. Researchers at Joslin Diabetes Center and Harvard John A. Paulson School of...
9-Jan-2020 2:25 PM EST Add to Favorites

Artificial pancreas system better controls blood glucose levels than current technology

A multi-center randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling...
16-Oct-2019 8:05 PM EDT Add to Favorites

The diabetes pandemic and the promise of connected care

Digital diabetes management systems (“connected diabetes care”) have the potential to become part of a new diabetes care model, augmenting the traditional practice of diabetes care by providing continuous and on-demand assistance that aligns...
3-Oct-2019 10:05 AM EDT Add to Favorites

High-fructose + high-fat diet damages mitochondria in the liver increasing risk of fatty-liver disease and metabolic syndrome

BOSTON – (October 1, 2019) – Researchers at Joslin Diabetes Center have found that high levels of fructose in the diet inhibit the liver’s ability to properly metabolize fat. This effect is specific to fructose. Indeed, equally high levels of...
1-Oct-2019 11:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: Mary-Elizabeth-Patti.jpg

After bariatric surgery patients have an increased risk of dangerous hypoglycemia. Dr. Mary-Elizabeth Patti, Joslin Diabetes Center/Harvard Medical School is available to discuss causes and treatment options.

9-Jan-2020 12:05 PM EST

Diabetes & Breast Cancer - Elizabeth Halprin MD Talks About the Important Struggle to Balance Both Diseases

12-Oct-2017 10:05 AM EDT

Newswise: Laffel21.jpg

Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies

6-Jan-2015 11:00 AM EST

Newswise: laffel28.jpg

Back to School with Dr. Lori Laffel from Joslin Diabetes Center

Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT

Expert Available: Bariatric Surgery for Diabetes

The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT

See All Experts

Our YouTube Videos

About

Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 16 NIH-designated Diabetes Research Centers in the U.S.

For more information, visit www.joslin.org or follow @joslindiabetes

Contacts

Jeffrey Bright
Director, Communications

jeffrey.bright@joslin.harvard.edu

617-309-1957

Twitter

close
0.43432